Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis.
about
Pain management for rheumatoid arthritis and cardiovascular or renal comorbidityProtective effect of methotrexate in patients with rheumatoid arthritis and cardiovascular comorbidityMyocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesisCardiovascular comorbidity in rheumatic diseases: a focus on heart failureImmunity, atherosclerosis and cardiovascular diseasePropensity-adjusted association of methotrexate with overall survival in rheumatoid arthritisThe effect of anti-rheumatic medications for coronary artery diseases risk in patients with rheumatoid arthritis might be changed over time: A nationwide population-based cohort study.Biologics and heart failure in rheumatoid arthritis: are we any wiser?Use of non-steroidal anti-inflammatory drugs and risk of incident myocardial infarction and heart failure, and all-cause mortality in the Australian veteran communityCardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatmentResults from the 5-year, phase IV RENEW (Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis) studyThe effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.Tumor necrosis factor-alpha antagonist use and heart failure in elderly patients with rheumatoid arthritis.The influence of rheumatoid arthritis disease characteristics on heart failure.Preventing Heart Failure in Inflammatory and Immune DisordersHeart failure among younger rheumatoid arthritis and Crohn's patients exposed to TNF-alpha antagonists.Selective COX-2 inhibitors, NSAIDs and congestive heart failure: differences between new and recurrent cases.Precocious atherosclerosis in rheumatoid arthritis: role of traditional and disease-related cardiovascular risk factors.Closing the loop on inflammation and atherothrombosis: why perform the CIRT and CANTOS trials?Nonsteroidal anti-inflammatory drugs and the heart: what is the danger?Review of the cardiovascular safety of COXIBs compared to NSAIDS.Non-steroidal anti-inflammatory drugs and cardiac failure: meta-analyses of observational studies and randomised controlled trials.Immune mechanisms in atherosclerosis, especially in diabetes type 2Moving beyond JUPITER: will inhibiting inflammation reduce vascular event rates?The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review.Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review.Cardiovascular disease risk in rheumatoid arthritis: progress, debate, and opportunity.Managing cardiovascular risk in patients with chronic inflammatory diseases.Biologic therapy in psoriasis: perspectives on associated risks and patient management.Decreased Cardiovascular Mortality in Patients with Incident Rheumatoid Arthritis (RA) in Recent Years: Dawn of a New Era in Cardiovascular Disease in RA?Impact of non-steroidal anti-inflammatory drugs on cardiovascular risk: Is it the same in osteoarthritis and rheumatoid arthritis?Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: a nationwide cohort study.The cardiovascular safety of celecoxib.[Safe use of biological therapies for the treatment of rheumatoid arthritis and spondyloarthritides].Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac: multivariate analysis of the MEDAL program.Prevalence of in-hospital nonsteroidal antiinflammatory drug exposure in patients with a primary diagnosis of heart failure.Absence of Fibrosis and Inflammation by Cardiac Magnetic Resonance Imaging in Rheumatoid Arthritis Patients with Low to Moderate Disease Activity.
P2860
Q24235971-086044BA-E435-42E5-B15D-0E8B22507F6FQ24630655-DA4CAD4F-078C-44F1-B048-21E2FCEC12D1Q24812557-A1DC3EB9-CA8F-498A-989D-0C166CA15FADQ26823443-9B6D65F9-E1A5-4BE6-9FDA-B559FB5C75E4Q28688590-37DCCCBE-9EEB-47DA-8896-CB2C728BC2CEQ28709376-C28CA4EE-2CD8-4762-B4ED-CA7270791364Q33848290-3F4AC14C-57EF-49BD-BC76-AB0E150E3CF0Q33898103-59E5FEA3-A45C-4120-B62E-079CBC8DA8ABQ33906348-70F07B58-A80D-4DFA-9A8D-C5A0503885FFQ33943374-5280C37E-1FA1-4C8E-950D-0AFE0DC5FF3DQ34810005-BB70742B-FB6F-4764-A146-AF9F9E354C6AQ35135831-92C2472D-33CA-4F29-864B-40628DD6770DQ35669374-9D501FAE-469D-4514-9215-F6EC822C1450Q35915244-D0CB6003-8A38-482E-9F7E-5E21BB178329Q35994802-BDE61AF8-061D-432F-B59F-F180F0F8C749Q36742762-789D4AB9-2EE7-4D41-8309-F54F4B8BFD5BQ36792634-B88F4CA1-CBCC-4836-AF47-66B56A7AB17BQ36951050-A0E8B2DE-B8D7-4633-9EC5-1C556154196EQ37026106-58E62831-C342-4C5D-A0A4-DB47453F2E07Q37133897-7A54CA6A-CF4B-468F-B933-8651DF57483BQ37178937-048DACF0-2F52-46D7-9CBE-CA83994F7E7CQ37257464-88021D23-C328-4BC6-AE89-1A11E93ED771Q37261617-F32A2F83-279B-46D7-8D7F-A76937012E70Q37279687-47BDDFFF-656E-4033-890B-082F498D2448Q37640953-133C3D19-B13F-4C22-8B5D-D7D87C1DD2CDQ37808889-83C4EE6A-B560-444F-B25F-C117C3998059Q37859676-84A94B22-D666-4044-AD82-B0B7A879A5BDQ37975943-3CC497BC-B60F-47AE-8186-D73687EBB8F4Q38020037-118D2403-2DC1-433E-A656-F5DF793CB3BEQ38401848-D0D8C52B-B22F-490B-8205-7CBDA1E00E26Q38962092-A56AC4E9-67F3-43C7-B2B5-1580D1CC5029Q39225848-F21DAB19-6D3D-4DE9-BE28-2C508D38C4DAQ40377176-F9F6D0C5-68D3-44D3-BD59-A2DF340E6073Q41176187-4B4A6E66-4CEA-40B2-8134-8FAA441CEE33Q46043878-C0BB0E5B-CAE6-46F8-B6B4-93A8DC812DF2Q48193986-81064D58-7949-4B90-A72C-7FBB5C1ADBA9Q52587395-8406E056-C935-4A48-87A2-C08DD7EF38B1
P2860
Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Anti-rheumatic drug use and ri ...... ilure in rheumatoid arthritis.
@en
Anti-rheumatic drug use and ri ...... ilure in rheumatoid arthritis.
@nl
type
label
Anti-rheumatic drug use and ri ...... ilure in rheumatoid arthritis.
@en
Anti-rheumatic drug use and ri ...... ilure in rheumatoid arthritis.
@nl
prefLabel
Anti-rheumatic drug use and ri ...... ilure in rheumatoid arthritis.
@en
Anti-rheumatic drug use and ri ...... ilure in rheumatoid arthritis.
@nl
P2093
P2860
P356
P1433
P1476
Anti-rheumatic drug use and ri ...... ilure in rheumatoid arthritis.
@en
P2093
P2860
P304
P356
10.1093/RHEUMATOLOGY/KEH610
P577
2005-03-22T00:00:00Z